在开始血液透析的患者中,降尿酸治疗限制了痛风爆发的发生:十年后期研究
Alexia Steelandt1, Ambre Hittinger2, Lukshe Kanagaratnam3
1Rheumatology Department, University Hospital of Reims, 45 Rue Cognacq-Jay, Reims, 51100, France.
BMC nephrology
|August 20, 2024
概括
尿酸降低疗法 (ULT) 在血液透析患者中显著降低了痛风发作. 这一发现表明ULT是一种保护因素,有助于在这个人群中更好地管理慢性痛风.
科学领域:
- 腎臟病學 (nephrology) 是一種醫學.
- 类风湿病学 类风湿病学
- 内部医学 内部医学
背景情况:
- 无法控制的痛风会导致关节问题和死亡率增加,特别是在透析患者中.
- 关于血液透析期间的痛风爆发和尿酸降低疗法 (ULT) 的疗效的现有研究是不确定的.
- 缺乏明确的指导方针来管理血液透析患者的慢性痛风.
研究的目的:
- 研究与未接受治疗的患者相比,用ULT治疗的血液透析患者中痛风爆发的发生率.
- 为了确定ULT是否可以降低血液透析患者的痛风发作频率.
主要方法:
- 在法国两个血液透析中心进行了一项回顾性队列研究.
- 包括在2005年1月至2015年9月期间开始血液透析的18岁以上患有痛风病史的患者.
- 在5年的随访期间,收集了人口统计,临床和痛风爆发 (通过晶体存在或临床诊断和科尔奇辛处方来定义) 的数据.
主要成果:
- 包括181名患者; 54%接受了ULT (主要是阿洛普林醇).
- 与没有ULT组 (50%) (p=0.0002) 相比,ULT组患者的痛风发作显著减少 (22.68%) (p=0.0002).
- ULT被确定为抗痛风爆发的保护因素 (HR:0.42),ULT患者更频繁地达到尿酸的目标血清水平.
结论:
- 尿酸降低疗法有效地限制了血液透析患者的新痛风发作,这些患者有痛风病史.
- 建议在风湿病学家和病学家之间进行合作,以更新透析患者ULT的治疗指南.
相关概念视频
01:16Antihypertensive Drugs: Action of Diuretics
636
Diuretics are antihypertensive drugs used to treat hypertension resulting from sodium and water retention. Sodium, vital for fluid balance and nerve or muscle function, is regulated by the kidneys through millions of nephrons. Blood enters nephrons via afferent arterioles, which branch into capillaries called glomeruli. These filter blood plasma, allowing water and solutes, like sodium ions, to pass through capillary walls into Bowman's capsule. The filtrate then flows through various...
636
01:11Renal Failure: Dose Adjustments
71
In patients with renal impairment, drugs undergo significant changes in their pharmacokinetics, which require dosage adjustments to ensure safe and effective therapy.
Reduced renal clearance and elimination rate are common outcomes of renal impairment. These alterations lead to a prolonged elimination half-life and an altered apparent volume of distribution for drugs. As a result, dosage adjustments are typically necessary to maintain optimal drug levels in the body.
However, dosage adjustments...
Reduced renal clearance and elimination rate are common outcomes of renal impairment. These alterations lead to a prolonged elimination half-life and an altered apparent volume of distribution for drugs. As a result, dosage adjustments are typically necessary to maintain optimal drug levels in the body.
However, dosage adjustments...
71
01:17Factors Affecting Renal Clearance: Renal Impairment
63
Renal dysfunction significantly impairs the renal clearance of drugs, leading to potential complications in drug therapy. Renal failure, which can be caused by various factors, poses a significant challenge in the elimination of drugs from the body.
One condition associated with renal failure is uremia. Uremia is characterized by impaired glomerular filtration and fluid accumulation in the body. This condition hinders the renal clearance of drugs, resulting in drug accumulation and potential...
One condition associated with renal failure is uremia. Uremia is characterized by impaired glomerular filtration and fluid accumulation in the body. This condition hinders the renal clearance of drugs, resulting in drug accumulation and potential...
63
01:27Dialysis
278
Renal failure occurs when the kidneys lose their ability to filter waste products from the blood effectively. It can be classified into two types: acute renal failure (ARF) and chronic renal failure (CRF).
Acute kidney injury develops suddenly and can be caused by pre-renal causes (e.g., hypovolemia, shock), intrinsic renal causes (e.g., acute tubular necrosis), or post-renal causes (e.g., urinary obstruction). In contrast, chronic renal failure progresses gradually over time and is often...
Acute kidney injury develops suddenly and can be caused by pre-renal causes (e.g., hypovolemia, shock), intrinsic renal causes (e.g., acute tubular necrosis), or post-renal causes (e.g., urinary obstruction). In contrast, chronic renal failure progresses gradually over time and is often...
278
01:25Antihypertensive Drugs: Direct Renin Inhibitors
513
The renin-angiotensin-aldosterone system (RAAS) is an intricate physiological pathway involving numerous enzymes and hormones, including renin, angiotensin-converting enzyme (ACE), angiotensin I and II, and aldosterone. Imbalances within this system increase the production of angiotensin II and aldosterone. Increased angiotensin II levels promote vasoconstriction and blood pressure elevation. Concurrently, higher aldosterone levels stimulate sodium and water reabsorption in the kidneys,...
513
01:26Heart Failure Drugs: Inhibitors of Renin-Angiotensin System
405
The activation of the sympathetic nervous system and the renin-angiotensin-aldosterone system (RAAS) contributes to cardiac remodeling, and inhibiting the RAAS is a pharmacological target in heart failure management. As a result, neurohumoral modulation is a crucial treatment principle for managing heart failure. This approach involves using medications like ACE inhibitors (ACEIs), angiotensin receptor blockers (ARBs), β-blockers, mineralocorticoid receptor antagonists (MRAs), and neutral...
405